Gladstone NOW: The Campaign Join Us on the Journey ✕
841 - 855 of 1510 Results Clear All
Get a deeper look at the most promising COVID-19 projects at Gladstone.
Gladstone Experts COVID-19
San Francisco Chronicle—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, joined other Bay Area women scientists in an editorial on how the coronavirus pandemic has caused disproportionate challenges for women’s careers, and threatens to reinforce long-standing inequities in the STEM fields.
Womens Initiative COVID-19 Pollard Lab
HIV remodels its target cells, facilitating spread from the female reproductive tract to the rest of the body, shows a new study at Gladstone Institutes.
News Release Research (Publication) HIV/AIDS Center for HIV Cure Research Infectious Disease Roan Lab Disease Models Single Cell
San Francisco Chronicle—Senior Investigator Warner Greene comments on how people can reduce risks when resuming get-togethers with friends or family.
Gladstone Experts COVID-19 Greene Lab
In this edition of the Newton Webinar Series, Jeanne Paz shared her lab’s unique approach to understanding the mechanisms of epilepsy and how it could lead to potential treatments.
Gladstone Experts Epilepsy Neurological Disease Paz Lab
When Science Speaks Podcast—Senior Investigator Warner Greene shares his team’s plan to screen FDA-approved drugs to find those that could be repurposed to fight COVID-19.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
Steve Finkbeiner explains how his lab uses machine learning and robotics to find answers to some of the world's most devastating diseases.
Center for Systems and Therapeutics Neurological Disease Finkbeiner Lab Big Data Robotic Microscopy
Inverse—A new study shows that speaking loudly can release droplets that contain coronavirus and have the potential to remain airborne for up to 14 minutes. Senior Investigator Warner Greene explains that any amount of the virus has the potential to cause infection.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
Learn more about Gladstone's COVID-19 research projects and how science will overcome this pandemic.
Gladstone Experts Genomic Immunology Infectious Disease
Where do you look for answers to COVID-19? One team at Gladstone is analyzing patient samples at the cellular level for answers to inform patient care and prevention.
Gladstone Experts COVID-19 Infectious Disease Greene Lab Roan Lab
As Gladstone scientists are moving to study COVID-19, urgent funding is needed to support their efforts.
Donor Stories COVID-19 Infectious Disease Ott Lab
While many are working from home, these scientists are continuing to go to the lab in hopes of making a discovery that could lead to the end of the COVID-19 pandemic.
Gladstone Experts Graduate Students and Postdocs COVID-19 Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab McDevitt Lab Ott Lab
San Francisco Chronicle—Gladstone announced the formation of two new institutes that will shape the future of infectious disease research. Senior Investigator Melanie Ott with take the helm of the newly formed Gladstone Institute of Virology, and Senior Investigator Alexander Marson will direct the Gladstone-UCSF Institute of Genomic Immunology.
Institutional News Genomic Immunology Infectious Disease Marson Lab Ott Lab
This generous gift will support Gladstone scientists who are pivoting their ongoing work to help fight the COVID-19 pandemic.
Donor Stories COVID-19 Roddenberry Stem Cell Center Srivastava Lab
